Bryan Johnson isn’t just dabbling in longevity—he’s all in. The tech entrepreneur, known for selling his company for $800 million, has turned his body into a full-time science experiment, throwing money at the aging process like it’s a problem that just needs a bigger budget. And when we say money, we’re not talking about a couple of fancy supplements and a gym membership. He reportedly spends over $2 million a year trying to slow down aging, testing everything from blood plasma transfusions to AI-driven biomarker tracking.
That’s more than most people make in a lifetime, all spent in the hopes of keeping his biological age as low as possible. So what exactly is he paying for? And is any of it actually working?
Where does the money go?
Johnson’s biggest expense isn’t some magic pill or futuristic therapy—it’s his lifestyle itself. His Blueprint project is a deeply controlled routine, designed to squeeze every bit of performance out of his body, monitored by a team of over 30 doctors and health experts. That alone is a massive financial commitment.
His home has basically been turned into a lab, fitted with medical-grade health tracking devices, high-tech sleep monitoring, and precise meal preparation. Everything he eats, drinks, and does is carefully measured. Even the lighting in his house is adjusted to match his body’s circadian rhythms. This level of hyper-optimization doesn’t come cheap. Reports estimate he’s spent at least $6.8 million transforming his living space into a personal longevity research center.
Then there’s the constant medical testing. He undergoes full-body MRIs, ultrasounds, and regular biomarker tracking to measure exactly how his body is responding to all the interventions. He’s not just seeing a doctor once a year for a check-up—he’s constantly testing, analyzing, and adjusting his routine based on data.
And of course, there are the treatments themselves. Johnson has experimented with some of the more controversial anti-aging interventions, including stem cell injections, gene therapy, and blood plasma transfusions. At one point, he received plasma from his teenage son in an attempt to see if younger blood could help rejuvenate his body. He later stopped the plasma therapy, saying it didn’t make much of a difference, but that experiment alone was estimated to cost thousands per session.
Then comes his supplement and diet routine. Some of these are basic longevity staples like NMN and resveratrol, while others are more experimental. Along with that, he follows an extremely strict vegan diet, with every meal planned down to the exact nutrient composition.
Exercise is another non-negotiable part of his plan. His workouts are designed to optimize muscle mass and cardiovascular health, both of which are linked to longevity. But this isn’t just a regular gym membership—his exercise routine is monitored as closely as his medical treatments to ensure he’s getting the best possible results.
Is all of this actually working?
The big question is: does spending millions actually slow down aging? Johnson claims that his biological age—the age his body “thinks” it is—is much lower than his actual age of 47. He’s reported test results that show some of his organs are functioning as if they belong to an 18-year-old, which is impressive if true. But at the same time, longevity science is still young, and no one knows for sure whether these extreme interventions will actually extend lifespan in the long run.
Some researchers argue that most of Johnson’s benefits could be achieved through basic health practices like fasting, regular exercise, good sleep, and a balanced diet—things that don’t require millions of dollars. Others believe that his approach is helping push the boundaries of longevity research, even if the average person can’t afford his level of intervention.
Marko is the founder and editor of LifeSpan Digest. With a deep interest in biotech, healthspan optimization, and regenerative medicine, he analyzes emerging discoveries and explores how science is reshaping human aging. Through expert insights and data-driven reporting, he provides readers with the knowledge to stay ahead in the rapidly evolving field of longevity.